[{"AccountsPayableCurrent_0_Q1_USD":7932000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":788000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":549000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":6401000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":484000.0,"DeferredTaxAssetsNetNoncurrent_0_Q1_USD":132000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":58586000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q1_USD":-19000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":149000.0,"EarningsPerShareDiluted_1_Q1_USD":0.07,"Land_0_Q1_USD":985000.0,"BuildingsAndImprovementsGross_0_Q1_USD":31928000.0,"SellingAndMarketingExpense_1_Q1_USD":6684000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":13653000.0,"PreferredStockNoParValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":419000.0,"CommonStockNoParValue_0_Q1_USD":null,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":2710000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":5537000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":133622000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":42789000.0,"OtherAssetsNoncurrent_0_Q1_USD":155201000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1368000.0,"LongTermDebtNoncurrent_0_Q1_USD":75824000.0,"Goodwill_0_Q1_USD":89958000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":5491000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":5113000.0,"InvestmentIncomeInterest_1_Q1_USD":111000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":19736000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":68557000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":6160000.0,"RestructuringReserve_0_Q1_USD":212000.0,"RestructuringCharges_1_Q1_USD":275000.0,"ReceivablesNetCurrent_0_Q1_USD":35318000.0,"PaymentsForRestructuring_1_Q1_USD":1199000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q1_USD":77000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":2768000.0,"OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_1_Q1_USD":-58000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.037,"OperatingLeaseRightOfUseAsset_0_Q1_USD":6041000.0,"OperatingLeasePayments_1_Q1_USD":387000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4480000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1333000.0,"OperatingLeaseLiability_0_Q1_USD":5813000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":380000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1132000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1456000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1310000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":967000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":712000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":616000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":6193000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":12209000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":8549000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":203000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-464000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":5038000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":1212000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":5100000.0,"RestructuringReserveAccrualAdjustment1_1_Q1_USD":-41000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":5096000.0,"EarningsPerShareBasic_1_Q1_USD":0.07,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5730000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":340000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_1_Q1_USD":2768000.0,"NetIncomeLoss_1_Q1_USD":2827000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":5288000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-340000.0,"LiabilitiesNoncurrent_0_Q1_USD":105983000.0,"LiabilitiesCurrent_0_Q1_USD":34853000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":338128000.0,"InventoryNet_0_Q1_USD":42827000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1434000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-550000.0,"ProfitLoss_1_Q1_USD":2827000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1199000.0,"GrossProfit_1_Q1_USD":27440000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8756000.0,"Depreciation_1_Q1_USD":1218000.0,"DeferredTaxLiabilitiesNoncurrent_0_Q1_USD":2910000.0,"CommonStockValue_0_Q1_USD":null,"CommonStockSharesIssued_0_Q1_shares":42827758.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":68557000.0,"AssetsCurrent_0_Q1_USD":152432000.0,"Assets_0_Q1_USD":338128000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1407000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-2265000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":1599000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":4026000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":30495000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":65935000.0,"Revenues_1_Q1_USD":47421000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":19981000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":28389000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":1187000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-712000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":96197000.0,"LegalFees_1_Q1_USD":320000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":99176000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3526000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-664000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1722000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":527000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":68681000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":42938000.0,"ShareBasedCompensation_1_Q1_USD":788000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":4824000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000000.0,"OperatingIncomeLoss_1_Q1_USD":5394000.0,"OperatingExpenses_1_Q1_USD":22046000.0,"InterestPayableCurrent_0_Q1_USD":958000.0,"InterestExpense_1_Q1_USD":767000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":37611000.0,"CommonStockSharesAuthorized_0_Q1_shares":71000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":2977000.0,"StockholdersEquity_0_Q1_USD":197292000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":5096000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":47421000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200207"}]